Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)

Conditions:   Diphtheria Vaccine Adverse Reaction;   Tetanus Vaccine Adverse Reaction;   Pertussis Vaccine Adverse Reaction;   Haemophilus Influenzae Type B Vaccine Adverse Reaction;   Hepatitis B Vaccine Adverse Reaction Interventions:   Biological: Recombinant Hepatitis B new Bulk vaccine;   Biological: DTP-HB-Hib with Recombinant Hepatitis B new Bulk vaccine;   Biological: Recombinant Hepatitis B vaccine (Registered BioFarma);   Biological: Pentabio Sponsors:   PT Bio Farma;   Hasan Sadikin General Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials